or
forgot password
  • cancer clinical trials in birmingham, AL

  • Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    A Study Evaluating INIPARIB in Combination With Chemotherapy to Treat Triple Negative Breast Cancer Brain Metastasis
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Estrogen Receptor Negative (ER-Negative) Breast Cancer, Progesterone Receptor Negative (PR-Negative) Breast Cancer, Human Epidermal Growth Factor Receptor 2 Negative (HER2-Negative) Breast Cancer, Brain Metastases
    Natural History Study of SCID Disorders
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    SCID, Leaky SCID, Omenn Syndrome, Reticular Dysgenesis, ADA Deficiency, XSCID
    Vorinostat and Radiation Therapy Followed By Maintenance Therapy With Vorinostat in Treating Younger Patients With Newly Diagnosed Pontine Glioma
    University of Alabama at Birmingham

    Trial Locations
    University of Alabama at Birmingham
    Children's Hospital of Alabama
    Childhood Mixed Glioma, Untreated Childhood Brain Stem Glioma
    Comparison of Metal and Plastic Stents for Preoperative Biliary Decompression
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Obstructive Jaundice, Pancreatic Cancer
    Treatment Algorithm to Reduce the Use of Vancomycin in Adults With Blood Stream Infection
    University of Alabama, Birmingham
    Birmingham, Alabama 35233
    Bacteremia
    Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer
    University of Alabama at Birmingham

    Trial Locations
    University of Alabama at Birmingham
    The Kirklin Clinic at Acton Road
    Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Stage IB Esophageal Cancer, Stage IIA Esophageal Cancer, Stage IIB Esophageal Cancer, Stage IIIA Esophageal Cancer, Stage IIIB Esophageal Cancer
    Pilot Study of Bisphosphonate Therapy (Zoledronic Acid) in Patients With Malignant Mesothelioma (UAB 0901)
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Mesothelioma
    RO4929097 and Letrozole in Treating Post-Menopausal Women With Hormone Receptor-Positive Stage II or Stage III Breast Cancer
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer
    PALACE 3: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Psoriatic Arthritis
    First-line Everolimus +/- Paclitaxel for Cisplatin-ineligible Patients With Advanced Urothelial Carcinoma
    University of Alabama Hematology Oncology Clinic at Medical West
    Birmingham, Alabama 35294
    Transitional Cell Carcinoma, Bladder Carcinoma, Urothelial Carcinoma
    Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors
    University of Alabama at Birmingham

    Trial Locations
    University of Alabama at Birmingham
    Children's Hospital of Alabama
    Recurrent Childhood Medulloblastoma, Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor
    Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma
    Children's Hospital of Alabama
    Birmingham, Alabama 35233
    Adult Rhabdomyosarcoma, Alveolar Childhood Rhabdomyosarcoma, Mixed Childhood Rhabdomyosarcoma, Pleomorphic Childhood Rhabdomyosarcoma, Previously Treated Childhood Rhabdomyosarcoma, Recurrent Adult Soft Tissue Sarcoma, Recurrent Childhood Rhabdomyosarcoma
    Avoiding the Hippocampus During Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
    UAB Comprehensive Cancer Center
    Birmingham, Alabama 35294
    Cognitive/Functional Effects, Metastatic Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma
    University of Alabama at Birmingham

    Trial Locations
    University of Alabama at Birmingham
    Children's Hospital of Alabama
    Adult Supratentorial Primitive Neuroectodermal Tumor (PNET), Childhood Supratentorial Primitive Neuroectodermal Tumor, Ewing Sarcoma of Bone, Extraosseous Ewing Sarcoma, Extraosseous Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Peripheral Primitive Neuroectodermal Tumor of the Kidney, Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor
    Vorinostat, Temozolomide, or Bevacizumab in Combination With Radiation Therapy Followed by Bevacizumab and Temozolomide in Young Patients With Newly Diagnosed High-Grade Glioma
    Children's Hospital of Alabama
    Birmingham, Alabama 35233
    Childhood High-grade Cerebellar Astrocytoma, Childhood High-grade Cerebral Astrocytoma, Childhood Spinal Cord Neoplasm, Untreated Childhood Brain Stem Glioma, Untreated Childhood Cerebral Astrocytoma
    Viral Therapy in Treating Young Patients With Relapsed or Refractory Solid Tumors
    University of Alabama at Birmingham

    Trial Locations
    University of Alabama at Birmingham
    Children's Hospital of Alabama
    Unspecified Childhood Solid Tumor, Protocol Specific
    Phase 1 and 2 Study of PX-866 and Cetuximab
    University of Alabama Birmingham

    Trial Locations
    University of Alabama Birmingham
    Birmingham Hematology and Oncology Assocs.
    Incurable Metastatic Colorectal Carcinoma, Incurable Progressive, Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
    Vaccine Therapy in Treating Patients With Persistent or Recurrent Cervical Cancer
    UAB Comprehensive Cancer Center
    Birmingham, Alabama 35294
    Cervical Cancer
    Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma
    UAB Comprehensive Cancer Center
    Birmingham, Alabama 35294
    Brain and Central Nervous System Tumors, Lymphoma, Lymphoproliferative Disorder, Small Intestine Cancer, Unspecified Childhood Solid Tumor, Protocol Specific
    Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Recurrent Melanoma, Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IV Melanoma
    A Safety Study in Patients With Advanced Solid Tumors
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Birmingham, Alabama 35294
    Advanced Solid Tumors
    A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
    Urology Centers of Alabama, PC
    Birmingham, Alabama 35209
    Prostatic Neoplasms
    A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
    University of Alabama Comprehensive Cancer Center
    Birmingham, Alabama 35294
    Acute Myeloid Leukemia
    A Study Of Everolimus, Trastuzumab And Vinorelbine In HER2-Positive Breast Cancer Brain Metastases
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    HER-2 Positive Breast Cancer
    A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
    Birmingham Hematology and Oncology Associates, LLC
    Birmingham, Alabama 35235
    Advanced Prostate Cancer, Prostatic Neoplasms
    Caspofungin Acetate or Fluconazole in Preventing Invasive Fungal Infections in Patients With Acute Myeloid Leukemia Who Are Undergoing Chemotherapy
    Children's Hospital of Alabama at University of Alabama at Birmingham
    Birmingham, Alabama 35233
    Fungal Infection, Leukemia, Neutropenia
    Abraxane With or Without Tigatuzumab in Patients With Metastatic, Triple Negative Breast Cancer
    University of Alabama at Birmingham (UAB)
    Birmingham, Alabama 35233
    Breast Cancer, Triple Negative Breast Cancer, Stage IV Breast Cancer, Metastatic Breast Cancer
    Airway Epithelium Gene Expression in the Diagnosis of Lung Cancer: AEGIS I
    University of Alabama
    Birmingham, Alabama
    Lung Cancer
    A Phase 1 Study of Brentuximab Vedotin Given Sequentially and Combined With Multi-Agent Chemotherapy for CD30-Positive Mature T-Cell and NK-Cell Neoplasms
    UAB Comprehensive Cancer Center
    Birmingham, Alabama 35294
    Lymphoma, Large-Cell, Anaplastic, Lymphoma, NK-cell, Lymphoma, T-cell
    Safety Study of Adenovirus/PNP Coupled With Fludarabine Phosphate to Treat Solid Tumors
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Head and Neck Cancer, Advanced Solid Tumors
    IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

    Birmingham, Alabama 35294
    Prostate Cancer, Prostatic Neoplasm
    Open Label Dose-Finding Study of TRC105 Plus Capecitabine for Metastatic Breast Cancer
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Metastatic Breast Cancer
    Study of TRC105 Combined With Standard-Dose Bevacizumab for Advanced Solid Tumors for Which Bevacizumab is Indicated
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Adult Solid Tumor
    Biological Therapy, Sargramostim, and Isotretinoin in Treating Patients With Relapsed or Refractory Neuroblastoma
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Recurrent Neuroblastoma
    Patients Treated for SCID (1968-2010)
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    SCID, ADA-SCID, XSCID, Leaky SCID, Omenn Syndrome, Reticular Dysgenesis